SCHEMBL13137014

SCHEMBL13137014

Cc1c(-c2ccc(CNC3CCC(C)(C)CC3)c(F)c2)ccc2nc[nH]c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 2/20 0.37
CD274 Q9NZQ7 2/20 0.37
BACE1 P56817 3/20 0.34
KCNH2 Q12809 2/20 0.34
BMPR1B O00238 1/20 0.33
BMPR1A P36894 1/20 0.33
TGFBR1 P36897 1/20 0.33
ACVRL1 P37023 1/20 0.33
ACVR1 Q04771 1/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 2/20 0.33
BTK Q06187 2/20 0.33
ALOX5AP P20292 3/20 0.32
FEN1 P39748 3/20 0.32
OPRL1 P41146 1/20 0.31
BRD4 O60885 1/20 0.31
ABL1 P00519 1/20 0.31
ENPP1 P22413 1/20 0.30
QPCT Q16769 2/20 0.30
QPCTL Q9NXS2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13137038 0.89 PDCD1 (0.37) PDCD1CD274BACE1KCNH2BMPR1B
SCHEMBL13137026 0.89 CD274 (0.33) CD274KCNH2OPRL1
SCHEMBL13137008 0.85 BMPR1B (0.32) PDCD1CD274BACE1KCNH2BMPR1B
SCHEMBL13136973 0.84 HRH3 (0.36) PDCD1CD274OPRL1QPCT
Hydrochloric Acid SCHEMBL3044289 0.84 PDCD1 (0.34) PDCD1CD274BACE1KCNH2BMPR1B
SCHEMBL13137013 0.84 ALOX5AP (0.36) PDCD1CD274BACE1TGFBR1BCHE
SCHEMBL13137219 0.83 MAP4K1 (0.35) PDCD1CD274BACE1KCNH2BMPR1B
SCHEMBL13137023 0.83 KCNH2 (0.35) KCNH2BMPR1BBMPR1ATGFBR1ACVRL1
Hydrochloric Acid SCHEMBL3034658 0.82 BACE1 (0.34) PDCD1CD274BACE1KCNH2BMPR1B
SCHEMBL13137034 0.82 OPRM1 (0.37) PDCD1CD274ACVR1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION 2010-09-02 US disclosed
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION 2010-09-02 US disclosed
WO-2008021851-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS OPRL1, OPRM1, OPRK1 PDCD1 3388/4885CD274 1330/4885BACE1 2970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.